Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Methotrexate prescribing alert

Potential prescribing errors surrounding methotrexate have been flagged up by the Government's National Patient Safety Agency.

The drug, used to treat conditions including severe psoriasis and moderate to severe rheumatoid arthritis, should only be taken once a week but several patients have mistakenly taken it every day.

The Committee on Safety of Medicines has received reports of prescription and dispensing errors, including a case in 2000, when a Cambridgeshire patient died after a practice inadvertently switched prescription of the drug from

a weekly to daily schedule.

The BNF urges GPs to pay attention to both the strength of tablets prescribed and dosing frequency. Methotrexate has been highlighted as part of an agency project to compile a database into areas of high clinical risk and publish plans to reduce adverse incidents.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say